Healthcare Artificial Intelligence Market Analysis, Share, Size, Trends, Industry Growth And Segment Forecasts

Healthcare Artificial Intelligence Market  Scenario

Global healthcare artificial intelligence market is presumed to register 51.9% CAGR during the forecast period (2018-2023) owing to the growing adoption of AI solutions among the healthcare providers, asserts Market Research Future (MRFR). Artificial intelligence (AI) is regarded as the next frontier for healthcare innovation. In the healthcare sector, artificial intelligence is being applied for sorting structured and unstructured data. Potential of AI spans across healthcare verticals. AI is considered to play a vital role in overcoming some of the toughest hurdles being faced by healthcare providers.

Drivers and Constraints Impacting the Market

The augmented focus on the use of artificial intelligence in the healthcare sector in the recent past. The adoption of AI solutions in the healthcare sector is growing rapidly owing to the growing number of healthcare applications of AI coupled with its rising demand for medical research. AI is also being employed in clinical laboratories, hospitals, and research facilities, which is further contributing to the growth of the market during the assessment period. Broader applications of AI and technological advancements in deep learning have further led to its increased adoption in the healthcare sector across the globe.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5681

Technological companies are highly investing in the development of AI for research and healthcare, which is further boosting the market growth. Moreover, AI in the healthcare sector is being used for prognosis, diagnosis, and therapy, thereby stimulating its growth during the appraisal period. AI has also developed several applications across the healthcare sector, such as delivery of health services, detection of diseases, drug discovery, and management of chronic conditions. AI in the healthcare sector ensures effectiveness and efficiency, which is further considered to trigger its adoption in the coming years. AI also enables the healthcare sector to overcome the crisis of human resource by providing productivity through automation of complicated tasks. Such factors are presumed to contribute to the market growth.

On the flip side, the high cost associated with the implementation of AI in the healthcare sector coupled with the stringent guidelines regulating AI are some of the major concerns considered to dampen the market growth during the appraisal period.

Global Healthcare Artificial Intelligence Market: Segmental Analysis

The global healthcare artificial intelligence market has been segmented on the basis of component, application, technology, end-user, and region.

By mode of component, the global healthcare artificial intelligence market has been segmented into software, hardware, and services.

By mode of application, the global healthcare artificial intelligence market has been segmented into virtual nursing assistant, robot-assisted surgery, clinical trial, dosage error reduction, automated image diagnosis, and preliminary diagnosis. Among these, the robot-assisted surgery segment is considered to hold the most significant share in the global market owing to the flexibility and high precision assured by robot-assisted surgeries while performing complex procedures.

By mode of technology, the global healthcare artificial intelligence market has been segmented into querying method, machine learning, and natural language processing. Among these, the machine learning segment is considered to demonstrate the highest CAGR owing to the ability to handle multi-dimensional data while facilitating a reduction in the process time cycle.

By mode of end-user, the global healthcare artificial intelligence market has been segmented into pharmaceutical & biotechnology companies, hospital & diagnostic centers, and academic & research laboratories. Among these, the hospital & diagnostic centers segment holds the largest market share owing to the extensive application of healthcare AI in robotic surgeries and diagnostic imaging.

Regional Insights

Geographically, the healthcare artificial intelligence market span across regions namely, Europe, America, Asia Pacific, Latin America, and the Middle East & Africa.

Among all the regions, America is predicted to dominate the global healthcare artificial intelligence market due to the growth witnessed in the biotechnology industry, presence of a developed healthcare sector, and rising cases of robotic surgeries.

The European region has secured the second position across the globe and is considered to garner USD 3453.4 million during the appraisal period. The growth is attributed to the extensive research and development activities for healthcare AI. Also, increased funding is responsible for catalyzing the proliferation of the regional market.

The Asia Pacific region is predicted to strike a relatively higher CAGR owing to the increasing therapeutic demand for chronic diseases coupled with the fast-developing healthcare sector.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/healthcare-artificial-intelligence-market-5681

Healthcare Artificial Intelligence Industry Updates

December 25, 2018: By harnessing digital health data, artificial intelligence, and deep learning, Shefayim-based health care start-up Zebra Medical Vision is aiming towards identifying the exotic diagnoses; the zebras by offering radiologists with high-performance algorithms in order to identify accurately and prevent breast, lung, cardiovascular, liver, and bone diseases.

Healthcare Artificial Intelligence Market Competitive Dashboard

The prominent players operating the global healthcare artificial intelligence market are Google, General Electric, IBM Watson Health, Microsoft Corporation, Intel Corporation, DEEP GENOMICS, Koninklijke Philips N.V., General Vision, NVIDIA Corporation, CloudMedx Inc., Next IT Corp., and Stryker.

Thyroid Disorder Market Trends, Industry Forecast, Applications, Growth Drivers, Trends & Demands - Global Forecast To 2025

Thyroid Disorder Market Overview:

Booming economies across the world is experiencing a radical shift to urbanization which, in a supple way, is creating a physiological disorder that is giving rise to the prevalence of various ailments. Diseases such as obesity, thyroid, autoimmune diseases are a common byproduct of this shift and trigger thyroid disorders in many which, if not checked, in time can cause severe brain damage. global thyroid disorder market is expected to rise with a moderate 3.1% CAGR during the forecast period (2013-2022) and can reach up to a valuation of USD 2400.8 million in the same period. The rising cases of thyroid disorder have become a concern for many initiating a collaborative agreement between private and public organizations to spread awareness. Efforts made by the pharmacies can be considered a tactical gambit in this context. As per the report of the International Thyroid Society, near about 20 million Americans are diagnosed with some form of thyroid disease, and around 12% can get affected by it in their lifetime. Chances of contracting the disease can aggravate if the patient has diabetes.

However, the treatment incurs high cost, and alternative treatment options are on the rise which can act as a headwind for the market. Side-effects of the treatment cannot be blind sighted as well. In considering the future of the market, this can seriously cause a plummeting effect.

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/2747

Thyroid Disorder Industry Trend:

New research by the University of Colorado School of Medicine Department of Radiation Oncology has revealed that thyroid tumors can be treated with stereotactic body radiation therapy (SBRT). The side-effects would be far lesser than the traditional method and the treatment promises the better chance of recovery. The University of Birmingham has recently called for universal testing for thyroid function to reduce the number of miscarriages and negative neurodevelopmental effects on the baby.

Segmentation:

The global thyroid disorder market can be segmented by treatment, disease indication, route of administration and end-users.

By treatment, the market is segmented into drugs & supplements, diagnostics, and surgery.

Based on disease indication, the market includes hypothyroidism, hyperthyroidism, and others. The hypothyroidism holds the largest market share.

Based on the route of administration, the market encompasses oral, injectable, and others. High efficacy and bioavailability made the oral segment the most preferable.

On the basis of end-users, the market comprises hospitals and home use.

Regional Analysis:

Region-specific segmentation includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa.

The Americas are currently leading the pack with the maximum share of the market. North America is spearheading the region with a considerable number of patients and advanced technologies used in treating the disease in multiple facilities. Europe assumes the second position. However, the APAC is set to register the maximum CAGR during the forecast period as the region has two countries such as China and India which are showing considerable expansion. Market incumbents are also launching strategies to raise awareness among the populace which can further boost the sector’s revenue.

Thyroid Disorder Market Competition:

The presence of several big shots across the globe is promising for the market as this will keep the market competitive and help it gain much from research and developments.

Some of the key players in this market are namely Allergan (Ireland), Abbott Laboratories (US), GlaxoSmithKline Plc (UK), Merck & Co., Inc. (US), Pfizer Inc. (US), RLC LABS (US), AbbVie (US), Mylan (US)and others.

Get More Information on Thyroid Disorder Market Research Report - Global Forecast till 2025 @ https://www.marketresearchfuture.com/reports/thyroid-disorder-market-2747

Radiology Information System (RIS) Market Size, Status, Revenue, Growth Rate, Services, Solutions, Analysis By Global Industry Revenue And Share Forecasts To 2024

Radiology Information System Market Overview:

Radiology Information System Market is drifting towards an unprecedented market valuation with a growth that is almost double of its 2017 valuation. The technology has stirred a lot of feathers in recent times with its revolutionary impact in the healthcare sector. Its impact can be felt in the imaging technology mostly where the physicians now mostly rely on the radiology imaging as its accuracy is better than the rest available in the market. The workflow has become much smoother in the radiology units due to the advents in a radiology information system. Integration of computer has further helped in sharing reports and better coordination which eases the process of diagnosis or treatments. The global radiology information system market can expect a rise up to USD 1100 million with an impressive 8.20% CAGR during the forecast period (2018-2023). Market Research Future’s (MRFR’s) report on the same provides some insights on the segmental analysis and drivers that can veer the radiology information system market towards better prospect.

Cloud technology is expected to take the radiology information system market further ahead in the coming years. The system requires bulk data storage which can work offline as well. Cloud provides easy sharing and storage of bulk data. At the same time, non-invasive diagnostic and curative means are getting traction due to which the radiology information system can experience much preference in the healthcare sector. Escalating investment in the healthcare sector can open up avenues for the radiology information system market which can lead to better prospects in the coming years.

However, risks are also several as storing information on a cloud platform can attract the attention of the online hackers. A data breach can make individuals vulnerable to potential threats. This can prove to be a significant irritant for the radiology information system market.

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/2464

Radiology Information System Market Segmentation:

The radiology information system market can be segmented by component, type, end-user, deployment, and region.

Deployment-based segmentation of the radiology information system market consists of on-premise and cloud-based/web-based.

Type-wise segmentation of the radiology information system market comprises standalone radiology information system and integrated radiology information system.

Based on the end-users, the radiology information system market can be segmented into research & academic institutes, hospitals & clinics and others.

Component-wise segmentation of the radiology information system market consists services, software, and hardware.

Regional Segmentation:

Region-specific analysis of the radiology information system market includes namely Asia Pacific (APAC), the Americas, the Middle East & Africa (MEA) and Europe.

The Americas is driving the market forward at present. The trend is expected to remain the same during the forecast period. This can be attributed to the cost-effectiveness of EHRs, technological advancement level, rising investment in the healthcare sector and increasing adoption of cloud computing and web-based solutions to facilitate procedures & simplify workload.

Europe and the APAC can become profitable growth pockets for the radiology information system market. The regions together control almost a 74.8 % share of the global market. The APAC region is enjoying the bliss of countries investing much in the healthcare sector to evolve as a possible medical tourism hub. Pharmaceutical companies are also eyeing for expansion in the region as it offers business prospects with minimal investment.

Radiology Information System Market Competitive Analysis:

Companies making a name for themselves in the radiology information system market are IMAGE information systems, Ambra health, Advanced data systems corporation, Carestream Health, eRAD, Epic systems, PERFECT Imaging, LLC, IBM Watson health, Allscripts healthcare solutions, Cerner Corporation, Medinformatix, Inc, Bayer AG, Koninklijke Philips N.V, GE healthcare, and NextGen Healthcare.

In 2018, Philips unveiled their latest IntelliSpace Discovery 3.0 that is a comprehensive, open platform where Artificial Intelligence gains prominence in radiology, and it enables radiologists to aggregate, normalize and anonymize data. This data can later be analyzed with algorithms.

In November 2018, QT Ultrasound launched eRAD RIS and PACS that can be considered the best possible breast imaging system with high-resolution transmission ultrasound images, without compression or radiation.

Get More Information on Radiology Information System Market Research Report - Global Forecast till 2023 @ https://www.marketresearchfuture.com/reports/radiology-information-system-market-2464

Artificial Heart Market Analysis, Cost, Competition, Applications, Gross Margin, Outstanding Growth, Status, Price, Business Opportunities And Key Findings

Global Artificial Heart Market Research Report: Information by Type (Heart-Lung Machine, Mechanical Heart, Total Artificial Hearts, Ventricular Assist Devices (VADs)), End User (Hospitals & Clinics, Specialty Centers) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2024

Artificial Heart Market Overview

An artificial heart is a pump which is designed to replace heart ventricles to restore normal functioning. Unavailability of donors, allograft coronary diseases, and various other limitations are increasingly favoring artificial hearts. They are used as a bridge to provide permanent mechanical cardiac support, and its success is being evidenced by number of artificial hearts working successfully across the globe. Market Research Future (MRFR) has recently published an in-depth report on the global artificial heart market and has cited rising incidence of cardiac disorders among the primary drivers of the growth of the artificial heart market. The report is a compilation of various other pertinent trend and factors that can impact the growth of the market in the coming years. As per MRFR's analysis, the artificial heart market is anticipated to register a CAGR of 15.1% 2019-2024.

Technological advancements, aggressive R&D activities, clinical trials, and massive support from research institutions and government bodies are factors propelling the growth of the market. Other vital factors include rapid greying of the global population and increasingly favorable reimbursement landscape. However, stringent regulatory framework is likely to be potential hindrance to the growth of the market.

Artificial Heart Market Segmentation

The artificial heart market has been segmented based on type and end user.

By type, the artificial heart market has been segmented into the heart-lung machine and mechanical heart. The mechanical heart segment has been further segmented into total artificial hearts and ventricular assist devices (VADs). The mechanical heart segment is expected to exhibit a higher CAGR over the forecast period.

By end-user, the artificial heart market has been segmented into hospitals & clinics, specialty centers, and others. 

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/7985

Regional Analysis

Region-wise, the artificial market has been segmented into the Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific (APAC).

The Americas is the leading market for artificial heart. Fast-track adoption of advanced technologies is the key factor that is supporting the growth of the market. Artificial heart is a relatively advanced and new technology and the Americas has been a frontrunner in the adoption of the artificial heart, which can be credited to the high prevalence of cardiovascular diseases and high healthcare expenditure. As per the estimates of the Center for Disease Control and Prevention (2015), around 630,000 Americans die from cardiovascular diseases every year. Moreover, the presence of a numvber of established market players in the region, who are actively involved in product innovation and development are also favoring the growth of the market. Furthermore, the region is experiencing a number of advancedments in technology which is supporting the growth of the market. Government initiatives in the form of R&D grants is also a supportive factor.

Europe is the second-largest artificial heart market and is expected to exhibit substantial growth over the forecast period. Cardiovascular diseases remain a leading cause of deaths across Europe. Aggressive R&D activities and prolific growth of the medical devices industry is augmenting the growth of the market.

APAC is poised to be the fastest-growing market for artificial heart. Established market players are eyeing on expanding their reach to the region. Given the high burden iof cardiovascular diseases in the region, market players are certain to find potential for growth in the healthcare sector of APAC. Low cost of R&D activities has encouraged various key players to set up their research facilities in the region. Singapore, South Korea, Japan, China, and Australia are key manufacturing pockets in the region.

The MEA market is anticipated to exhibit the least growth over the forecast period. The growth of the market is subdued by factors such as the lack of awareness regarding the device, poor economic conditions, and underdeveloped healthcare sector. Unavailability of skilled medical professionals and lack of the required healthcare infrastructure are also detering factors.

Artificial Heart Market Competitive Landscape

Cleveland Heart, Inc., Thoratec Corporation, ABIOMED, Abbott, CryoLife, Inc., BiVACOR Inc., CARMAT, and SynCardia Systems, LLC are the eminent players ion the global artificial heart market.

Get More Information on Artificial Heart Market Research Report - Global Forecast till 2024 @ https://www.marketresearchfuture.com/reports/artificial-heart-market-7985

Artificial Heart Industry Updates

August 2019 - researchers at the University of Birmingham have developed a device that could improve care for patients with artificial heart pumps. Sometimes, patients waiting for a heart transplant opt for a left ventricular assist device (LVAD), commonly known as a heart pump. It requires an open heart surgery to restore normal blood flow of the heart and patients require to carry the device all the time, which can significantly impact the life of the individual. The new research has developed a patient reported outcome measure (PROM), which is likely to improve clinical care for such patients. It would also help to provide recommendations for future policies, designs, and research.

Bioidentical Hormones Market Key Players, Supply, Consumption, Demand, Growth, Application, Analysis And Forecast To 2023

Global bioidentical hormones market is expected to reach USD 400 million by 2023, and the market is projected to grow at a CAGR of 5.2 % during the forecast period 2017-2023.

Bioidentical Hormones Market Overview

Bioidentical hormones although are created in a lab they are very similar to the hormones produced by the human body.  Hence, they can be defined as man-made hormones. These hormones are customized as per the prescription or are compounded by a pharmacist, based on the doctor’s demand. 

Bioidentical hormones are then used as a treatment for people whose own hormones are imbalanced. Bioidentical hormones just as hormones produced by the human body can control almost all tasks in the body including sex and brain function, growth and the breakdown of food, etc.

Hormonal imbalance can cause increased risks including low energy, weight gain, muscle atrophy, hair loss, depression, anxiety, mood swings, trouble sleeping, and hot/ cold flashes & night sweats for women who are going through their menopause.

People witnessing these symptoms are prescribed with the hormone-replacement therapy where the provider first talks with the patients and asks them to undergo a blood test to determine the specific symptoms and then orders the test.

Get Free PDF Sample Of Bioidentical Hormones Market Research Report- Global Forecast till 2023 @ https://www.marketresearchfuture.com/sample_request/4187

Unlike, the synthetic hormones, bio-identical hormones do not create any cause side effects and increased risks. These hormones rarely have side effects and, if they do, the provider might need to adjust the dosage. As a result, bio-identical hormones are preferred widely.

Increasing prevalence of hormonal changes or imbalance in hormones led by the sedentary lifestyle, lack of nutrition, and the aging drives the market for bioidentical hormones, creating a huge demand.  Resultantly, the bioidentical hormones market garners huge demand, uptake, and hence the colossal growth on the global platform.

Recognizing the kind of the growth, the market witnesses today, an eminent research firm, Market Research Future (MRFR) in its recently published study report confirms that the global bioidentical hormones market will reach USD 400 MN, registering approximately 5.2 % CAGR during the forecast period (2017-2023).

Additional factors substantiating the market growth include the environmental changes, increasing industrialization and urbanization. Improving economic conditions are certainly providing a vast impetus to the market growth, availing the quality healthcare.

On the other hand, factors such as the demand and supply gap of feedstock required in the production of these hormones are estimated to obstruct the market growth over the forecast period, increasing their prices unreasonably. 

Bioidentical Hormones Global Market – Segmentations

MRFR has segmented the report into four key dynamics for an easy grasp; 

By Types : Estrogens, Progesterone, and Testosterone among others.

By Product Types: Tablets & Capsules, Creams & Gels, Injectable, and Patches & Implants among others.

By End-Users: Hospitals & Gynecology Clinics, Academic and Research among others.

By Regions: Europe, North America, APAC and the Rest-of-the-World. 

Global Bioidentical Hormones Market – Regional Analysis

The North American region dominates the global bioidentical hormones market, in terms of both market size as well as revenue. The extensive use of medications and high expenditure on health care majorly lead the market growth in the region.  Besides, factors such as the fastest uptake of new drugs alongside the presence of major research companies drive the bioidentical hormones market in the region.

The European region accounts for the second-largest market in the world due to high per capita income and healthcare expenditures. A well-developed healthcare sector along with the resurging economy in the region substantiates the market growth of bioidentical hormones in the region. Some of the European countries such as the U.K, Germany, and France boost the market growth in this region.

The Asia Pacific region accounts for a promising market for bioidentical hormones, closely following the European market. Factors such as the ever-increasing population encourage the use to bioidentical hormones, creating a significant demand for healthcare. China and India backed by their respective, fast-growing healthcare sector will be leading the APAC bioidentical hormones market. 

Global Bioidentical Hormones Market – Competitive Analysis

Highly competitive bioidentical hormones market appears fragmented due to the presence of several large and small-scale players. Producers compete based upon price and brand, emphasizing upon new product development initiatives, and geographical expansion. Matured players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain a competitive advantage and thus to maintain their positions in this market.

Key Players:

Some of the eminent leaders of the market include BioTE Medical, SottoPelle, Advantage Pharmaceuticals, Inc., Neuva Aesthetics, Full Life Wellness Center, Defy Medical, and Biostation.

Industry/ Innovation/ Related News:

October 29, 2018 – TherapeuticsMD Inc. (US) a leading global Pharmaceutical company announced receiving its third FDA approval of the year, Bijuva, a menopause remedy that combines two bioidentical hormones.

Bijuva, an oral soft gel that contains ingredients are artificially produced but chemically identical to hormones made naturally by women's bodies such as estradiol and progesterone which are commonly used in hormone therapies to treat menopause symptoms such as hot/cold flashes. The company is now all geared up to launch first-ever bioidentical hormone combo Bijuva.

Browse the market data and information spread across 80 pages with data tables and figures of the report “Bioidentical Hormones Market Information: By Types (Estrogens, Progesterone, Testosterone, others) By Product Types (Tablets and Capsules, Creams and Gels, Injectable, Patches and Implants, and others) By End Users - Global Forecast Till 2023” in-depth alongside table of content (TOC) at:  https://www.marketresearchfuture.com/reports/bioidentical-hormones-market-4187

Chronic Disease Management Market Analysis, Share, Size, Trends, Industry Growth And Segment Forecasts To 2025

Chronic Disease Management Market Overview

Global Chronic Disease Management Market is expected to grow at a CAGR of 17.5% over the forecast period from 2017 to 2023, according to a new research report from Market Research Future (MRFR). The global chronic disease management market is mainly driven by the growing prevalence of chronic diseases and the increasing realization of the need for specialized, dedicated chronic disease management solutions.

Chronic disease management includes monitoring a patient with chronic diseases and bringing all aspects of their lifestyle in line with the desired effect of the medication. Such facilities are usually established by hospitals looking to expand into more dedicated care for chronic diseases. The growing prevalence of chronic diseases around the world has been the major driver for the global chronic disease management market in recent years. Chronic diseases such as cancer and diabetes are rising in prevalence continuously, leading to a need for dedicated facilities. Close to 1.7 million new cases of cancer were registered in the U.S. in 2016, whereas diabetes is estimated to have claimed more than 420 million adult patients around the world. The growing prevalence of these diseases is likely to drive the global chronic disease management market over the forecast period.

Several chronic diseases require patients to adhere to a certain lifestyle for easy and quick recovery. Adhering to this lifestyle can be difficult in one’s own home, as one may forget certain aspects. Such conditions are avoided in chronic disease management, as a physician keeps track of the lifestyles of the patients, allowing them to keep up with the required activities and prohibitions through the rehabilitation period.

On the other hand, the high prices of chronic disease management could emerge as a blow to the global chronic disease management market’s prospects over the forecast period. However, the increasing government support for chronic disease management centers has the potential to overcome this barrier in the coming years.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/981

Chronic Disease Management Market Competitive Analysis:

Leading players in the global chronic disease management market include TriZetto Corporation, Pegasystems Inc., Wellcentive Inc., i2i Systems Inc., Allscripts Healthcare Solutions Inc., Epic Corporation Inc., Infosys Limited, Harmony Information Systems Inc., ZeOmega Inc., HealthSmart Holdings Inc., Medecision Inc., AxisPoint Health, and Phytel Inc.

Chronic Disease Management Industry Update/News

In April 2019, University Hospitals Geauga launched a new chronic disease management clinic. Such moves are aimed primarily at the geriatric demographic, which may find it difficult to remember particular aspects of the lifestyle to be followed.

Chronic Disease Management Market Segmentation:

The global chronic disease management market is segmented on the basis of service types, application, deployment, end user, and region.

On the basis of the service type, the chronic disease management market is segmented into consulting services, implementation services, educational services, and others.  

On the basis of the application, the chronic disease management market is segmented into asthma, cancer, cardiovascular, diabetes, stroke, and others.  

On the basis of deployment, the market is segmented into on-premise, web-based, and cloud-based.

On the basis of end user, the market is segmented into provider and payer.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/chronic-disease-management-market-981

Chronic Disease Management Market Regional Analysis:

North America, followed by Europe, is the leading regional market for chronic disease management and is likely to retain the position over the forecast period. The high level of technological innovation in North America and the increasing government expenditure on healthcare have allowed for the development of a number of effective chronic disease management facilities. The widespread prevalence of a number of chronic diseases in North America is also a major driver for the chronic disease management market in the region. Diseases such as cancer and diabetes are widely prevalent in North America, helped along by unhealthy lifestyle factors such as excessive smoking and excessive sugar consumption.

Asia Pacific is the fastest growing regional market for chronic disease management. Due to the relatively advanced and specialized nature of chronic disease management, only a small number of facilities have been established in Asia Pacific so far, with Japan taking up the lion’s share in the region’s chronic disease management market.

Mammography Market: Demand, Business Opportunities, Competitive Landscape, Key Findings, Future Insights, Market Revenue And Threat Forecast By 2025

Mammography Market Overview

Mammography is a breast imaging technology used as a screening method for the faster detection of signs of breast cancer in women experiencing no symptoms. Mammograms are low dose x-ray images that can also detect and diagnose breast disease in women experiencing symptoms like pain, a lump, skin dimpling, and nipple discharge.

At the same time, this screening method allows doctors to push boundaries with this latest imaging technologies to precisely visualize cancerous cells and study its behavior and growth. All these factors commutatively add up to deliver effective outcomes in the treatment of breast cancer and other disease related to breast.

Therefore, the mammography is considered as a proven method for earlier detection in breast screening programs. As a result, the mammography market is accruing rapidly. Undoubtedly, technological advancements transpired in the medical science and biotechnology are some of the major driving forces that escalate the market on the global platform.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2443

Considering the traction, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global mammography market will register a CAGR over 22% during 2016 – 2022, accruing pervasively by 2022. The market is predominantly driven by the increase in the number of breast cancer patients, spreading awareness about health, and increase in healthcare expenditures.

Additional factors such as increasing population, genetic mutations (abnormal changes), and exposures to harmful radiation are substantiating the market growth. Simultaneously, increasing healthcare expenditures and increasing government initiatives are supporting the market growth, spreading awareness among people.

On the other hand, factors such as the high cost of the mammography devices and long approval time of clinical trials are obstructing the market growth. Nevertheless, the unmet clinical needs, especially in the developing regions, are expected to support market growth, providing ample scope to the market to evolve further.

Although less deadly, breast cancer is the most frequently diagnosed of all cancers after skin cancer and its prevalence is on the constant rise. Over the past few years, breast cancer deaths have declined dramatically, however, the mortality rate among women from underdeveloped regions is still disproportionally high. Many women from medically underdeveloped regions do not have adequate access to screening mammograms.

Global Mammography Market – Segments

MRFR has segmented the report into three key dynamics for an easy grasp;

By Technology: Digital Mammography, 3D Mammography, C-View 2D, Breast Tomosynthesis Contrast Enhance Mammography, and Analog among others.

By Application: Screening and Diagnostic among others.

By Regions: North America, Europe, Asia Pacific, and the Rest-of-the-World.

Global Mammography Market – Geographical Analysis

The North American region dominates the global mammography market owing to the presence of leading market players and well-developed technologies. The regional market growth is largely supported by the mammography market in the US that is heading with the large patient pool and substantial healthcare expenditures.

Furthermore, the increasing prevalence of breast cancer fuelled by the consequences of the wrong lifestyle fosters the market growth in the region. Also, factors such as well-spread awareness among people towards the benefits of mammography and increasing government support for research and development, support the market growth.

The European region commands the second position in terms of the market share due to the strong government support and funds. The mammography market in this region is rapidly emerging as a lucrative space owing to the increasing number of breast cancer patients and the proliferation of advanced treatment facilities alongside the availability of skilled medical professionals.

The Asia Pacific region accounts for a promising market for the mammography. Factors substantiating the market growth include the increasing prevalence and the spreading awareness among people about breast cancer. The presence of emerging economies with massive populations that create a huge demand for good healthcare. Proliferating markets in India and China contribute to the market growth in the region majorly.

Global Mammography Market – Competitive Landscape

The fiercely competitive, mammography market appears fragmented with the several large and small-scale players forming a competitive landscape. Significant investments are made in the field of R&D to bring novelties in this screening tool and its clinical trials. Through the strategic initiatives such as partnership, acquisition, expansion, product & technology launch, and collaboration, these players try to gain a competitive edge in the market.

Key Players:

Some of the imminent players in the mammography market are Siemens Healthcare GmbH, Toshiba Medical Systems Corporation, FUJIFILM Holdings Corporation, Shimadzu Corporation, General Electric Company, Koninklijke Philips, Hitachi Medical Corporation, Carestream Health, Inc., and Hologic, Inc.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/mammography-market-2443

Industry/ Innovation/Related News:

January 02, 2019 ---- UC Health (US) published its study on new mammogram its doctors conducted. The study reveals that the new mammogram will help save lives. The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) was developed in conjunction with approximately 130 institutions participating in. The ultimate goal of the study was to achieve a health algorithm or (an) imaging strategy for women so that we can better detect breast cancer at earlier stages.

December 14, 2018 – Southwest Medical Center Board (SWMC board – US) approved the purchase of a 3D mammography unit at SWMC in Liberal. The unanimously approved the new 3D unit will replace the current 2D digital mammography system giving access to patients to enhanced breast imaging services closer to home.

Vascular Closure Devices Market 2019: Global Opportunities, Growth Factors and Forecast

Vascular Closure Devices Market Overview

Vascular closure devices are referred to as medical devices, which are extensively used to seal puncture of the femoral artery in the patient who underwent interventional procedures or angiography procedures. These devices are an alternative to manual compression as they provide immediate sealing femoral artery site. global vascular closure devices market is projected to grow significantly over the forecast period. It is estimated that global vascular closure devices market size is expected to register a CAGR of 6.8% during the forecast period of 2018–2023.

The increased approvals for vascular closure devices, support, and initiatives by the government, soaring demand for advanced treatment, and rising research and clinical trials are some of the primary growth stimulants of the vascular closure devices market. High-efficiency rate of these devices will encourage the market growth in the future. Factors like rising prevalence of obesity and soaring incidences of cardiovascular diseases will contribute to the market growth in the review period. The increased popularity of femoral artery cardiac catheterization, shortening of hemostasis time, and increased success rate of VCDs for improved patient comfort are considered some of the potential growth factors of the market.

Medical facilities are rapidly shifting towards minimally invasive procedures, which is likely to influence the market globally. The use of radiotherapy and imaging technologies has further created growth opportunities in the market. Moreover, the implementation of imaging technologies in order to monitor cardiac functions will trigger the demand for heart surgeries, thereby increasing the sales of VCDs globally.

On the contrary, complications associated with VCDs, like risk of infections and leg ischemia will slow down the market growth in the foreseeable future.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5704

Vascular Closure Devices Market Competitive Dashboard

The top players operating in the vascular closure devices market include Terumo Corporation, Abbott Laboratories, Cardiva Medical Inc., Cardinal Health Inc., Medtronic plc, Essential Medical, Inc., Morris Innovative, Inc., TZ Medical, Inc., Vasorum Ltd., Merit Medical Systems, Inc., Vascular Closure Systems, Inc., Transluminal Technologies LLC, and Vivasure Medical Ltd.

Vascular Closure Devices Market: Segmental Analysis

By product type, the market is segregated into active vascular closure devices, passive vascular closure devices, and external hemostatic devices. Of these, the passive vascular closure devices are estimated to expand at a significant rate. Collagen-based passive approximators are extensively used due to the advantages these devices offer, like short ambulation time for patients, ease of use, and fewer complications compared to manual compression.

The access segment comprises femoral access and radial access. Of these, the femoral access segment is predicted to gain prominence as a considerable number of physicians and cardiologists are opting for femoral access in interventional techniques.

Based on procedures, the market is classified into interventional radiology/vascular surgery and interventional cardiology. Of these, the interventional cardiology segment is likely to gain prominence owing to the high incidences of cardiovascular disease among the global population and rapid growth of the obese population.

The application segment constitutes therapeutic intervention and diagnostic intervention.

By end users, the market is segmented into specialty centers, hospitals & clinics, ambulatory surgery centers, and others. Of these, the hospital's segment will gain prominence due to favorable reimbursement policies.

Vascular Closure Devices Market Regional Frontiers

Geographically, the vascular closure devices market spans across Europe, America, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, the vascular closure devices market share is dominated by America, due to the surging awareness regarding vascular closure devices, especially among medical professionals and rising funding for research. The soaring research and funding by the government have further propelled the market growth in the region. Europe will acquire the second spot in the global market and is likely to retain its position in the long run. The growth can be credited to the several initiatives taken by private and public organizations.

Meanwhile, the Asia Pacific will expand at the fastest rate owing to technological advancements, which has resulted in the development of cost-effective vascular closure devices. The existence of untapped areas and unmet need of patients has attracted the attention of industry players, which has further encouraged the market growth in the APAC. Several market players in the region are improving their product catalog to gain access into the untapped territory. This has further encouraged the market growth in the coming years.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704

Vascular Closure Devices Industry Updates

August 2019: A cardinal health company, Cordis has recently declared that the company has received CE Mark approval for MYNX CONTROL Vascular Closure Device (VCD). The device is equipped with a novel deployment system, which enables ease of use and predictable deployment.

Doxorubicin Market 2019 Overview, Segmentation, Application, Technology, Industry Challenges And Key Vendors

Doxorubicin Market Analysis

The global doxorubicin market size is projected to have a steady growth rate at a whopping 6.5% CAGR over the forecast period (2016-2023). Doxorubicin or anthracycline is a form of chemotherapy medicine that is used for diminishing or reducing growth of cancer cells via blocking the topo isomerase enzyme. This drug is utilized alone or together with other drugs for treating various types of cancers such as ovarian, stomach, bladder, lung, breast, non-Hodgkin and Hodgkin lymphomas, neuroblastoma and specific forms of leukemia. The treatment rests upon the cancer type being treated, how well a patient responds to the medicine and other forms of drugs that the patient takes at the time of the treatment. Doxorubicin comes in both lyophilized power form and injection solution. It is generally administered intravenously through central venous catheters (CVC) or peripheral inserted central line catheters (PICC).

There are abundant factors that is propelling the growth of the doxorubicin market. These factors as per the MRFR (Market Research Future) report include increasing prevalence of various forms of cancer, boost in geriatric population, growing awareness of cancer treatment and inclusion of the drug in different applications such as AIDS-related Kaposi Sarcoma and neuroblastoma, growing cancer treatment awareness programs, large presence of ablation and surgical centers and technological advancements. On the contrary stringent regulatory authorities, various cost suppression measures undertaken by different governments and numerous side effects resulting from doxorubicin are factors that are likely to hamper the growth of the doxorubicin market. Some of the common side effects of taking doxorubicin include inflammation of the mouth, rash, vomiting, bone marrow suppression, hair loss, allergic reactions namely anaphylaxis, damage of tissue owing to the position of the injection, heart damage, treatment associated to leukemia and radiation recall. All these side effects and more are affecting the doxorubicin market growth.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7376

Doxorubicin Market Segmentation

MRFR report offers a broad segmental analysis of the doxorubicin market on the basis of application and distribution channel.

Based on application, the doxorubicin market is segmented into leukemia, ovarian cancer, stomach cancer, prostate cancer, bone sarcoma, breast cancer, gastric cancer, liver cancer and others. Of these, prostate and breast cancer will have the largest share in the market over the forecast period.

Based on distribution channel, the doxorubicin market is segmented into retail pharmacy, hospital pharmacy and others. Of these, hospital pharmacy is projected to lead the market over the forecast period.

Doxorubicin Market Regional Analysis

By region, the doxorubicin market covers growth opportunities and latest trends across Americas, the Middle East and Africa, Europe and Asia Pacific. Of these, the Americas will remain the vital contributor in the market over the forecast period. Factors attributed for the market growth in this region include favorable regulatory authorities and reimbursement, awareness about cancer treatment, increase in cancer cases and presence of leading manufacturers. The doxorubicin market in Europe will account for the second major share owing to rising healthcare expenditure and increasing pool of cancer patients. In the APAC region, the doxorubicin market is projected to grow at the fastest pace over the forecast period. This is on account of growing geriatric population especially in China and India, growing number of manufacturers looking for opportunities in developing countries, government investment and initiatives for the healthcare sector development and increasing cancer treatment awareness programs. On the other hand, the doxorubicin market in the Middle East and Africa is prognosticated to have minimal share over the forecast period.

Doxorubicin Market Key Players

Leading players profiled in the doxorubicin market include GLENMARK PHARMACEUTICALS LTD, Teva Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Sandoz, Novartis AG, Accord Healthcare, Janssen Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Pfizer, Inc, and various others.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/doxorubicin-market-7376

Doxorubicin Industry News

March 2019 - SourcingLink.net, Inc. (SNET) has lately revealed the news of entering into a worldwide exclusive licensing agreement with leading biopharmaceutical company, NanoSmart Pharmaceuticals, Inc. This agreement has been made for the right of utilizing nanoparticle platform technologies of NanoSmart for developing and commercializing doxorubicin’s improved formulations to treat human cancers. It will impact countless cancer patients all across the world and also offer the increasing global cancer population with enhanced therapy options, including patients with unmet rare cancer needs.

Kidney Dialysis Equipment Market 2019: Industry Overview, Driving Factors, Segments, Regional Analysis And Competitive Analysis – Forecast To 2023

Kidney Dialysis Equipment Market Overview

Worldwide kidney dialysis equipment market is likely to accrue USD 16.5 billion over the forecast period 2018-2023. The market has been expected to expand at 5.7% CAGR during 2018-2023. Chronic kidney disease or CKD is a chronic condition which critically affects a patient’s life quality. Kidney dialysis is the most preferred cure for serious conditions where both the kidneys of a person is damaged. However, this treatment is also sporadically used for curing patients with a single damaged kidney. On average, the kidney of a fit person filters about 150 quarts of blood per day. When the kidney fails to perform efficiently, the waste automatically gathers in the blood resulting in coma and even death. In such cases, dialysis acts as the savior. It prevents the waste and toxin products formation in the blood. Dialysis acts as an artificial kidney that finds wide application in filtering the patient’s blood during kidney damage, kidney dysfunction, kidney failure, and for eliminating surplus impurities from kidneys.

Improved healthcare infrastructure, growth in the prevalence of dialysis patients, loss of appetite resulting weight loss, embracing updated technologies in dialysis, adoption of sedentary lifestyle, increasing acidosis, heart failure, and surging number of ESRD (End Stage Renal Disease Patients) drive the kidney dialysis equipment market to a great extent. Additionally, cost-effective portable dialysis device, rapidly growing geriatric population, rising frequencies of diabetes and hypertension issues and preference for dialysis over kidney transplantation. However, the risks and difficulties involved, soaring cost of dialysis procedures, rules and regulations pertaining to dialysis, costly cures, and time consumption are likely to propel the growth of the kidney dialysis equipment market over the forecast period.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6302

Kidney Dialysis Equipment Market Segmentation

The worldwide kidney dialysis equipment market has been segmented based on apparatus type, end-user, and type.

Based on apparatus type, the kidney dialysis equipment market has been segmented into peritoneal dialysis device, consumables, hemodialysis apparatus, and continuous renal replacement therapy systems. The hemodialysis equipment has been sub-segmented into tunneled hemodialysis catheters, vascular access devices, bloodline system, solutions, filters, concentrates, dialyzers and hemodialysis machine. The peritoneal dialysis equipment has been sub-segmented into dialyzers, filters, concentrates, solutions, and automated peritoneal dialysis devices. Of these, the hemodialysis equipment market is likely to hold the major market share.

Based on end-user, the kidney dialysis equipment market has been segmented into home care, ambulatory services, hospitals, and in-center dialysis settings.

Based on type, the kidney dialysis equipment market has been segmented into peritoneal dialysis, hemodialysis, and Continuous Renal Replacement Therapy (CRRT). Hemodialysis has been sub-segmented into short daily hemodialysis, conventional hemodialysis, and nocturnal hemodialysis. The Peritoneal dialysis has been sub-segmented into Continuous Cycling Peritoneal Dialysis (CCPD), Intermittent Peritoneal Dialysis (IPD), Tidal Peritoneal Dialysis, and Continuous Ambulatory Peritoneal Dialysis (CAPD).

Kidney Dialysis Equipment Market Regional Analysis

Geographically, the kidney dialysis equipment market has been segmented across Europe, North America, Middle East and Africa, and Asia Pacific. North America has been anticipated to dominate the market owing to the growing prevalence of kidney failure, hypertension, increasing cases of diabetes and surged reusable income within the population. Europe represents the second largest market owing to progressive medical compensation and advanced organizations. The kidney dialysis device market in APAC possess an unparalleled market prospect on account of the growing instances of kidney failure, rise in disposable income, low rates of organ transplantation, and prevalence of aged population. The Middle East and Africa have minimal share in the global kidney dialysis equipment market owing to low per capita income and stringent government policies.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/kidney-dialysis-equipment-market-6302

Kidney Dialysis Equipment Market Key Players

The global kidney dialysis equipment market has been dominated by key players such as Teleflex Incorporated, Hemoclean CO., LTD, Terumo Corporation, Rockwell Medical, Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation), Nxstage Medical, Inc., Mar Cor Purification, Inc. (A Cantel Medical Company), Nikkiso Co., Ltd., Diaverum Deutschland GmbH, Nipro Corporation, Baxter International Inc., B. Braun Melsungen AG, Fresenius Medical Care AG & Co. Ka., and Davita Healthcare Partners Inc.

Psoriasis Treatment Market Size, Global Trends And Forecast By Regions, Segmentation, Applications, Dynamics, Development Status And Outlook

Psoriasis Treatment Market Analysis

As per the latest report published by Market Research Future (MRFR), Psoriasis Treatment Market is expected to register 7.3% CAGR during the forecast period of 2019 to 2025 and is expected to reach USD 13.1 Billion in 2025. Psoriasis is a common skin disorder and is linked with the immune system. Stress, cold and skin infection can trigger the condition.

Psoriasis usually effect the skin on the scalp, knees and elbows. The condition may have an effect on patient’s psychology, leading to depression and social stigma. Most number of cases are found in individuals aged between 50 and 70. The exact cause of the condition is yet to be confirmed. However, some suggestions point towards environmental factors, genetics and auto-immunity as possible root cause of psoriasis. The condition is also associated with a slew of co-morbidities such as diabetes, ophthalmologic pathologies, psoriatic arthritis, inflammatory bowel disease. A report from WHO suggests that the prevalence rate differs from county to country ranging between 0.09% and 11.43%. Plaque psoriasis the most common type of psoriasis, accounting for nearly 90% of all psoriasis cases. The prevalence rate has increase in recent years, which is fuelling the demand for psoriasis treatment.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2769

Sales of psoriasis medication, therapeutics and drugs have also increased owing the increased penetration of psoriasis treatment in rural and remote areas in fast developing countries. Also, the risk factors associated with psoriasis are becoming more prominent, which is likely to reflect favourably on the market during the forecast period. The condition has a chronic nature, through the psoriasis treatment reduces the effect substantially but does not assures complete cure. The treatment options that are currently available are either offer temporary relief or of symptomatic nature. At the same time, risk of side-effects from psoriasis drugs continues to be a major challenge for pharmaceutical companies. The focus remains on developing novel biologic drugs, the arrival  of blockbuster drugs such as IL-17 inhibitors and TNF-α inhibitors can be accredited to the increased R&D efforts. During the forecast period, drug development is expected to remain a key focus area for market players. 

Psoriasis Treatment Market: Segmental Analysis

MRFR’s report also offer a detailed segmental analysis of the market based on drugs type, route of administration, and mechanism of action. By drug type, the market has been segmented into biologics and small molecules. Based on route of administration, the market has been segmented into injectable, tropical and oral. By mechanism of action, the market has been segmented into interleukin blockers, phosphodiesterase inhibitors and TNT inhibitors. 

Global Psoriasis Treatment Market: Regional Analysis

The market has been covered across North America, South America, Europe, Asia Pacific (APAC) and the Middle East & Africa (MEA). Among these, North America is identified as the most attractive market for psoriasis treatment. North America is followed by Europe. Europe psoriasis treatment market is expected to witness a healthy growth over the next couple of year. Meanwhile, the market in APAC is also witness a surge, demand for psoriasis treatment has increased on the region owing to improvement in healthcare system and increased healthcare expenditure.

Psoriasis Treatment Market: Competitive Landscape

MRFR’s in its report has profiled some of the top-notch companies that are currently operating in the global psoriasis treatment market, which include Amgen, Johnson & Johnson, AbbVie, Novartis International AG, Merck and Co. Inc, Eli Lilly and Pfizer Inc. 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/psoriasis-treatment-market-2769

Industry News

• Indian multinational pharmaceutical Sun Pharmaceutical Industries has recently introduced it latest plaque psoriasis treatment drug Ilumya also known as tildrakizumab-asmn in the US market.
• Canada-based multi specialist pharmaceutical company Bausch Health Companies Inc. is reportedly gearing up to distribution of its BRYHALI™ Lotion to the wholesale pharmaceutical distributors in the U.S in coming days.